Hello Flow community,
I have a few questions from looking over the above publication.
1. How many are using CD65 in diagnosis of myeloid leukemias or for acute
leukemias of ambiguous lineage. I noticed the scoring system from the
European Group for immunologic Classification of leukemia gives it a score
of 1. I have not used it and wondered how prevalent and useful it is for
others.
2. How common is the use of FMC7 for CLLs. In the section on CLLs, there
is a scoring system of one point each which uses
SIg weak,
CD5 pos,
CD23 pos,
CD79b/CD22 weak and
FMC7 neg
looking for a score of 4-5 for CLL. I am not using FMC7 but find CD43
helpful as well as intensity of stain and of course CD5 and CD23. I also
use intensity of CD20 which I do not see listed. What is your common
practice. Also, how many are using CD79b. I am not familiar with that
particular antibody.
thanks again,
bessie
--
Bessie Kam Email: bkam@dls.queens.org
The Queen's Medical Center, Pathology FAX: 808-547-4045
Phone: 808-547-4271
This archive was generated by hypermail 2b29 : Sun Jan 05 2003 - 19:01:40 EST